EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer

Nancy Y Greenland, Janet E Cowan, Bradley A Stohr iD, Jeffry P Simko, Peter R Carroll, Emily Chan iD

Histopathology · 2024-03 · 84 (4) · 614-623

DOI: 10.1111/his.15102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, online erschienen am 27.11.2023. Verfasst von Nancy Y Greenland und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pathology and Urology, UCSF-Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Prostate-Specific Antigen, Prostatic Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

A recent outcome‐based, radical prostatectomy study defined > 0.25 mm diameter to distinguish large versus small cribriform glands, with > 0.25 mm associated with worse recurrence‐free survival. This study evaluates whether identification of > 0.25 mm cribriform glands in Grade Group 2 patients at biopsy is associated with adverse pathology at radical prostatectomy. Methods and results Tumours containing biopsy slides for 133 patients with Grade Group 2 prostate cancer with subsequent radical prostatectomy were re‐reviewed for large cribriform glands (diameter > 0.25 mm). The primary outcome was adverse pathology (Grade Groups 3–5; stage pT3a or greater, or pN1). The secondary outcome was recurrence‐free survival. Cribriform pattern was present in 52 of 133 (39%) patients; of these, 16 of 52 (31%) had large cribriform glands and 36 of 52 (69%) had only small cribriform glands. Patients with large cribriform glands had significantly more adverse pathology at radical prostatectomy compared to patients with small cribriform glands and no cribriform glands (large = 11 of 16, 69%; small = 12 of 36, 33%; no cribriform = 25 of 81, 31%; χ 2 P ‐value 0.01). On multivariate analysis, large cribriform glands were also associated with adverse pathology, independent of age, prostate‐specific antigen (PSA)/PSA density at diagnosis, year of diagnosis and biopsy cores percentage positive (global P ‐value 0.02). Large cribriform glands were also associated with increased CAPRA‐S surgical risk score (Kruskal–Wallis P ‐value 0.02).

Conclusions

Large cribriform glands using a diameter > 0.25 mm definition in Grade Group 2 patients on biopsy are associated with increased risk of adverse pathology at radical prostatectomy. The presence of large cribriform histology should be considered when offering active surveillance for those with Grade Group 2 disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostate-Specific AntigenProstatic NeoplasmsMaleHumansNeoplasm GradingBiopsyProstateProstatectomy

Stichwörter der Autor:innen

Gleason 7Grade Group 2 (GG2)active surveillanceintermediate-risklarge cribriformprostate cancer

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Departments of Pathology and Urology, UCSF-Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
  • Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

ORCID-Profile: Bradley A Stohr, Emily Chan

Zitieren

APA

Greenland, N. Y., Cowan, J. E., Stohr, B. A., Simko, J. P., Carroll, P. R., & Chan, E. (2024). Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer. Histopathology, 84(4), 614-623. https://doi.org/10.1111/his.15102

Vancouver

Greenland NY, Cowan JE, Stohr BA, Simko JP, Carroll PR, Chan E. Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer. Histopathology. 2024;84(4):614-623. doi:10.1111/his.15102

BibTeX
@article{Greenland2024,
  author = {Greenland, Nancy Y and Cowan, Janet E and Stohr, Bradley A and Simko, Jeffry P and Carroll, Peter R and Chan, Emily},
  title = {Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer},
  journal = {Histopathology},
  year = {2024},
  volume = {84},
  number = {4},
  pages = {614--623},
  doi = {10.1111/his.15102}
}
Kostenlos starten →